Evidence map›Paper›PMID 33729982›Full record

ArticleJMIR formative research2021

Online Tool for the Assessment of the Burden of COVID-19 in Patients: Development Study.

Esther M J van Noort, Danny Claessens, Catharina C Moor, Carlijn A L Van Den Berg, Marise J Kasteleyn, Johannes C C M In 't Veen, Onno C P Van Schayck, Niels H Chavannes

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in JMIR formative research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.9field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 11 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Esther M J van Noort *Department of Public Health and Primary Care, Leiden University Medical Center, Leiden, Netherlands.ORCID https://orcid.org/0000-0001-7142-1126
Danny Claessens *Department of Family Medicine, Care and Public Health Research Institute School for Public Health and Primary Care, Maastricht University Medical Centre, Maastricht, Netherlands.ORCID https://orcid.org/0000-0002-6290-625X
Catharina C Moor *Department of Respiratory Medicine, Erasmus Medical Center, Rotterdam, Netherlands.ORCID https://orcid.org/0000-0002-5295-2877
Carlijn A L Van Den BergErasmus Medical Center, Rotterdam, Netherlands.ORCID https://orcid.org/0000-0002-5421-996X
Marise J Kasteleyn *Department of Public Health and Primary Care, Leiden University Medical Center, Leiden, Netherlands.ORCID https://orcid.org/0000-0001-7751-7516
Johannes C C M In 't Veen *Erasmus Medical Center, Rotterdam, Netherlands.ORCID https://orcid.org/0000-0001-6828-2612
Onno C P Van Schayck *Department of Family Medicine, Care and Public Health Research Institute School for Public Health and Primary Care, Maastricht University Medical Centre, Maastricht, Netherlands.ORCID https://orcid.org/0000-0002-3016-1476
Niels H Chavannes *Department of Public Health and Primary Care, Leiden University Medical Center, Leiden, Netherlands.ORCID https://orcid.org/0000-0002-8607-9199
Erasmus MC · NLLeiden University Medical Center · NLMaastricht University Medical Centre · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe impact of COVID-19 has been felt worldwide, yet we are still unsure about its full impact. One of the gaps in our current knowledge relates to the long-term mental and physical impact of the infection on affected individuals. The COVID-19 pandemic hit the Netherlands at the end of February 2020, resulting in over 900,000 people testing positive for the virus, over 24,000 hospitalizations, and over 13,000 deaths by the end of January 2021. Although many patients recover from the acute phase of the disease, experience with other virus outbreaks has raised concerns regarding possible late sequelae of the infection.

objectiveThis study aims to develop an online tool to assess the long-term burden of COVID-19 in patients.

methodsIn this paper, we describe the process of development, assessment, programming, implementation, and use of this new tool: the assessment of burden of COVID-19 (ABCoV) tool. This new tool is based on the well-validated assessment of burden of chronic obstructive pulmonary disease tool.

resultsAs of January 2021, the new ABCoV tool has been used in an online patient platform by more than 2100 self-registered patients and another 400 patients in a hospital setting, resulting in over 2500 patients. These patients have submitted the ABCoV questionnaire 3926 times. Among the self-registered patients who agreed to have their data analyzed (n=1898), the number of females was high (n=1153, 60.7%), many were medically diagnosed with COVID-19 (n=892, 47.0%), and many were relatively young with only 7.4% (n=141) being older than 60 years. Of all patients that actually used the tool (n=1517), almost one-quarter (n=356, 23.5%) used the tool twice, and only a small group (n=76, 5.0%) used the tool 6 times.

conclusionsThis new ABCoV tool has been broadly and repeatedly used, and may provide insight into the perceived burden of disease, provide direction for personalized aftercare for people post COVID-19, and help us to be prepared for possible future recurrences.

Indexed as

ABCoV toolassessmentCOVID-19long-term impactmonitoringonline patient platformpatient outcomepatient-reported outcomestool

Identifiers

PMID33729982
PMCPMC8015936
OpenAlexW3138445137

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.